Lithium’s ability to enhance mitochondrial function, reduce ROS, and inhibit GSK-3β has shown promise in preclinical models of PD, where it helps protect dopaminergic neurons from oxidative damage (Nassar and Azab, 2014). This evidence concerns the gene GSK3B and Parkinson disease.